These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8102473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
    Batinić D, Robey FA.
    J Biol Chem; 1992 Apr 05; 267(10):6664-71. PubMed ID: 1551875
    [Abstract] [Full Text] [Related]

  • 3. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN, Phelan M, Mallinson M, Norcross MA.
    J Virol; 1991 Mar 05; 65(3):1543-50. PubMed ID: 1995952
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M, Abrescia P, Dettin M, Di Bello C, Guardiola J.
    Virology; 1991 Dec 05; 185(2):820-8. PubMed ID: 1720590
    [Abstract] [Full Text] [Related]

  • 6. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K, Kimura T, Jones IM, Morita F, Ikuta K.
    Vaccine; 1994 Mar 05; 12(4):343-50. PubMed ID: 8178557
    [Abstract] [Full Text] [Related]

  • 7. Sulphated polysaccharides exert anti-HIV activity at differing sites.
    Harrop HA, Rider CC, Coombe DR.
    Biochem Soc Trans; 1992 May 05; 20(2):163S. PubMed ID: 1397551
    [No Abstract] [Full Text] [Related]

  • 8. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
    Harrop HA, Coombe DR, Rider CC.
    AIDS; 1994 Feb 05; 8(2):183-92. PubMed ID: 8043225
    [Abstract] [Full Text] [Related]

  • 9. Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay.
    Gilbert M, Brigido L, Müller WE, Hansen JE, Ezekowitz RA, Mills J.
    J Virol Methods; 1993 Apr 05; 42(1):1-12. PubMed ID: 8100569
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides.
    Okada T, Patterson BK, Gurney ME.
    Biochem Biophys Res Commun; 1995 Apr 26; 209(3):850-8. PubMed ID: 7537501
    [Abstract] [Full Text] [Related]

  • 11. Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.
    Benjouad A, Chapuis F, Fenouillet E, Gluckman JC.
    Virology; 1995 Jan 10; 206(1):457-64. PubMed ID: 7831801
    [Abstract] [Full Text] [Related]

  • 12. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M, De Clercq E.
    Gen Pharmacol; 1997 Oct 10; 29(4):497-511. PubMed ID: 9352294
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a unique scrambled peptide derived from the CD4 CDR3-related region which shows substantial activity for blocking HIV-1 infection.
    Ohki K, Kumagai K, Mitsuda S, Takano T, Kimura T, Ikuta K.
    Vaccine; 1993 Oct 10; 11(6):682-6. PubMed ID: 8322494
    [Abstract] [Full Text] [Related]

  • 14. [Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].
    Meshcheriakova DV, Andreev SM, Sidorova MV, Vafina MG, Az'muko AA, Petrukhina AO, Khaitov RM.
    Vestn Ross Akad Med Nauk; 1992 Oct 10; (9-10):47-52. PubMed ID: 1283721
    [Abstract] [Full Text] [Related]

  • 15. Analysis of interaction between sulfated polysaccharides and HIV oligopeptides by surface plasmon resonance.
    Battulga T, Tumurbaatar O, Ganzorig O, Ishimura T, Kanamoto T, Nakashima H, Miyazaki K, Yoshida T.
    Int J Biol Macromol; 2019 Mar 15; 125():909-914. PubMed ID: 30521896
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.
    Kuipers ME, Huisman JG, Swart PJ, de Béthune MP, Pauwels R, Schuitemaker H, De Clercq E, Meijer DK.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr 15; 11(5):419-29. PubMed ID: 8605586
    [Abstract] [Full Text] [Related]

  • 17. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding.
    Choe HR, Sodroski J.
    J Acquir Immune Defic Syndr (1988); 1992 Apr 15; 5(2):204-10. PubMed ID: 1732513
    [Abstract] [Full Text] [Related]

  • 18. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S, Gulick R, Chess L.
    J Immunol; 1989 Aug 15; 143(4):1149-54. PubMed ID: 2545782
    [Abstract] [Full Text] [Related]

  • 19. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J, Liao HX, Torres JV, Matthews TJ, Robinson J, Haynes BF.
    AIDS Res Hum Retroviruses; 1997 May 20; 13(8):657-64. PubMed ID: 9168234
    [Abstract] [Full Text] [Related]

  • 20. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.
    Este JA, Schols D, De Vreese K, Van Laethem K, Vandamme AM, Desmyter J, De Clercq E.
    Mol Pharmacol; 1997 Jul 20; 52(1):98-104. PubMed ID: 9224818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.